GLP1 medications like Wegovy and Ozempic can help with weight loss but may also be able to help with psychiatric symptoms from depression, bipolar disorder, anxiety, and more. But are GLP1s safe in psychiatry, and how do they compare to nutritional interventions like a ketogenic diet to treat mental health disorders? Dr. Roger McIntrye, a world-renowned psychiatrist and researcher, joins Metabolic Mind to discuss the potential roles of GLP1 medications and ketogenic therapy, and how clinicians and patients could consider their use.

Expert featured in this video:
Roger McIntyre, MD
[ Ссылка ]
Twitter/X: @rogersmcintyre

About us:
Metabolic Mind™ is a nonprofit initiative incubated by Baszucki Group. Our mission is to provide education and resources in the emerging field of metabolic psychiatry, including ketogenic interventions for mental disorders.

Our channel is for informational purposes only. We are not providing individual or group medical or healthcare advice nor establishing a provider-patient relationship. Many of the interventions we discuss can have dramatic or potentially dangerous effects if done without proper supervision. Consult your healthcare provider before changing your lifestyle or medications.

Timestamps
0:00 Introduction
2:40 The evolution of psychiatry
6:49 The impact of GLP1s on mental health
11:44 Understanding GLP1s as psychiatric medications
15:07 Ketogenic therapy for mental illness
17:51 Considerations before recommending GLP1s or ketogenic therapy for mental illness
26:49 Does diet impact mental health?
27:28 Psychiatry's shifting focus to brain energy
33:58 The future improvement of psychiatry
37:54 Conclusion

#MetabolicMind
#KetoForMentalHealth
#MetabolicPsychiatry
#BipolarTreatment
#KetogenicMetabolicTherapy
#NutritionalKetosis
#MentalIllness
#Bipolar
#GLP1
#Ozempic
#Wegovy
#weightloss
#AlternativeTreatment

свернуть